Pneumococcal Conjugate Vaccine (PCV)

Pneumococcal disease is caused by Streptococcus pneumoniae bacteria and is a leading cause of pneumonia, meningitis, and sepsis in children under 5. PCV13 (Prevenar 13) protects against 13 strains of the bacteria. India introduced PCV under the UIP in 2017 in select states, expanding nationally.

The Pneumococcal Conjugate Vaccine (PCV) is recommended for 6 weeks, 14 weeks, and booster at 9 months. It falls under the Childhood vaccine category. Consult your doctor to confirm if this vaccine is right for you based on your health history and existing immunity.

The Pneumococcal Conjugate Vaccine (PCV) has an efficacy of 97% against invasive pneumococcal disease caused by vaccine serotypes. This means it provides significant protection against Pneumococcal pneumonia and Meningitis. Efficacy may vary based on age, health status, and the specific strain encountered.

Common side effects include: Pain and redness at injection site (very common); fever (common); irritability; decreased appetite. These are typically mild and resolve within 1–3 days. Serious allergic reactions are rare — if you experience difficulty breathing, hives, or rapid heartbeat after vaccination, seek emergency care immediately.

The Pneumococcal Conjugate Vaccine (PCV) should be avoided by: Severe allergy (anaphylaxis) to any component; previous anaphylactic reaction to diphtheria toxoid-containing vaccines. Defer during acute severe febrile illness.. Always inform your healthcare provider of your full medical history before vaccination.

The Pneumococcal Conjugate Vaccine (PCV) typically costs Free (UIP selected states) / ₹3,500–₹4,500 per dose (private) in India. Government health centres may offer it free or at subsidised prices for eligible age groups. Private hospitals and clinics may charge differently. Additional fees may apply for administration.